Sökresultat

Filtyp

Din sökning på "Victor" gav 2085 sökträffar

BBHB52 Litteraturlista, höstterminen 2024

BBHB52 Litteraturlista, höstterminen 2024 Fastställd av institutionsstyrelsen eller motsvarande, 2020-04-07, reviderad 2024-05-20. ❶ Ej tillgänglig elektroniskt; måste köpas eller lånas på bibliotek. ② Tillgänglig i fulltext via Lubsearch (sök på ISBN/ISSN). ③ Tillgänglig i fulltext via Libris, URL eller DOI. ④ Tillgänglig som pdf via kurswebben. ② Allan, David, ”’The advantages of literature’: Th

https://www.ht.lu.se/media/utbildning/dokument/kurser/BBHB52/20252/BBHB52_Bibliotekens_historia_Litteraturlista_HT2025_250516.pdf - 2025-07-27

No title

Institutionen för kulturvetenskaper Avdelningen för idé- och lärdomshistoria LITTERATURLISTA Kurslitteratur för ILHA26: Idé- och lärdomshistoria, fortsättningskurs (30 hp) Delkurs 1: Idéhistoriska platser (7,5 hp) Fastställd av institutionsstyrelsen, reviderad och godkänd av kursplanegruppen 2020-06-04. Justerad 2021-12-04 Reviderad av kursplanegruppen, 2024-12-08 Litteraturen söks i LUBcat och/el

https://www.ht.lu.se/media/utbildning/dokument/kurser/ILHA26/20252/Litteraturlistan_2025_ILHA26_Ide_historiska_platser_1_.docx - 2025-07-27

Charlotte ling publications march 2018

1 1 List of publications - Charlotte Ling Total of 94 original publications, 16 invited review papers and 8 book chapters since 1999 H-index: 34; Number of citations ~6300 Original publications 1. Milana Kokosar, Anna Benrick, Alexander Perfilyev, Emma Nilsson, Thomas Källman, Claes Ohlsson, Charlotte Ling and Elisabet Stener-Victorin A Single Bout of Electroacupuncture Remodels Epigenetic and Tra

https://www.ludc.lu.se/sites/ludc.lu.se/files/charlotte_ling_publications_march_2018.pdf - 2025-07-27

List of publications c ling sept 2017

1 1 List of publications - Charlotte Ling Total of 90 original publications, 15 invited review papers and 8 book chapters since 1999 H-index: 33; Number of citations ~5500 Original publications 1. Backe MB, Andersson JL, Bacos K, Christensen DP, Hansen JB, Dorosz JJ, Gajhede M, Dahlby T, Bysani M, Kristensen LH, Ling C, Olsen L, Mandrup-Poulsen T. Lysine demethylase inhibition protects pancreatic

https://www.ludc.lu.se/sites/ludc.lu.se/files/list_of_publications_c_ling_sept_2017.pdf - 2025-07-27

Sasnetworkreportactivity2016

Layout 1 SASNET detaljerad aktivitetsrapport 2016 ---------------------------------------------------- ...sammanställd av Lars Eklund JANUARY 2016 SASNET participation in Thiruvananthapuram seminar on Access to Justice • The Department of Law at University of Kerala, India, organized an International Interdisciplinary Seminar on ”Access to Justice: Trends and Issues” on 7–9 January 2016 in Thiruva

https://www.sasnet.lu.se/sites/sasnet.lu.se/files/sasnetworkreportactivity2016.pdf - 2025-07-27

Previous prize-winners

The Prize for Future Innovations is awarded by Lund University and Sparbanken Skåne. Since the start in 2017 we have seen hundreds of exciting, innovative, and sometimes downright weird ideas. Every year, the prize jury has the pleasant but difficult job of selecting the winners. So here they are, the winners of Lund University and Sparbanken Skåne’s Future Innovations Prize.  2023 Category Employ

https://www.innovation.lu.se/en/futureinnovations/previous-prize-winners - 2025-07-25

Diana Mulinari

Senior professor Contact details Email: diana [dot] mulinari [at] genus [dot] lu [dot] se Phone: +46 46 222 97 04Organisation Gender Studies Service point: 31 WebpageDiana Mulinaris profile in Lund University research portalOther affiliations Researcher Gender StudiesBackgroundThe role of mothers in doing the political was the topic of my PhD at the Department of Sociology. Lund University.  After

https://www.gender.lu.se/diana-mulinari - 2025-07-26

Jayne Svenungsson

Researcher Contact details Email: jayne [dot] svenungsson [at] ctr [dot] lu [dot] se Phone: +46 46 222 43 39Organisation Systematic Theology Room number: LUX:B327 WebpageJayne Svenungssons profile in Lund University research portalOther affiliations Researcher MECW: The Middle East in the Contemporary World Researcher Centre for Advanced Middle Eastern Studies (CMES) Principal investigator Christi

https://www.cmes.lu.se/jayne-svenungsson - 2025-07-26

Text bfa3

Therese Bülow Jørgensen The Gaze of a Player: Better Smize while Entering the Woods, 2020 Video installation. 14 min. loop They didn’t even remember how they got here. The feeling of having been put on pause was there when they woke up, but that cannot be true, can it? This is another space. It’s a gateway, an ornament made out of wool, moist, light wear and pine forest. It is a documentation of a

https://www.khm.lu.se/en/sites/khm.lu.se.en/files/text_bfa3.pdf - 2025-07-27

Arbetsorganisation och ledarskap, MAMF15

Kursen Arbetsorganisation och ledarskap avslutades med en konferens där studenterna presenterade sina projektarbeten. Dessa arbeten är sammanställda i artiklar med olika teman kopplat till dagens arbetsliv. Årets konferens speglar aktuella frågor och utmaningar i näringslivet såsom ökad automation, företags sociala ansvar (CSR), konflikthantering, framgångsfaktorer för nya projektledare, modernt l

F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

We evaluated the predictive value of interim positon emission tomography (I-PET) after one course of chemoimmunotherapy in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). One hundred and twelve patients with DLBCL were enrolled. All patients had PET/computed tomography (CT) scans performed after one course of chemotherapy (PET-1). I-PET scans were categorized according to Inte

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial

Aims Delcasertib is a selective inhibitor of delta-protein kinase C (delta-PKC), which reduced infarct size during ischaemia/reperfusion in animal models and diminished myocardial necrosis and improved reperfusion in a pilot study during primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI). Methods and results A multicentre, double-blind trial was perform

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1) : final survival analysis of a randomised, controlled, phase 3 trial

BACKGROUND: The OVHIPEC-1 trial previously showed that the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery resulted in improved progression-free and overall survival compared with cytoreductive surgery alone at 4·7 years of follow-up in patients with stage III epithelial ovarian cancer who were ineligible for primary cytoreduction. We report the fina

Hybrid speciation driven by multilocus introgression of ecological traits

Hybridization allows adaptations to be shared among lineages and may trigger the evolution of new species1,2. However, convincing examples of homoploid hybrid speciation remain rare because it is challenging to demonstrate that hybridization was crucial in generating reproductive isolation3. Here we combine population genomic analysis with quantitative trait locus mapping of species-specific trait

Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias

Background and Clonal haematopoiesis of indeterminate potential (CHIP), the age-related expansion of blood cells with preleukemic mutaAims tions, is associated with atherosclerotic cardiovascular disease and heart failure. This study aimed to test the association of CHIP with new-onset arrhythmias.Methods UK Biobank participants without prevalent arrhythmias were included. Co-primary study outcome

Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial

PURPOSE In the randomized open-label phase III OVHIPEC trial, the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery (CRS) improved recurrence-free and overall survival in patients with stage III ovarian cancer. We studied the cost effectiveness of the addition of HIPEC to interval CRS in patients with ovarian cancer. PATIENTS AND METHODS We constructed

Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC

BACKGROUND: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has improved the survival in selected colorectal cancer patients with peritoneal metastases. In these patients, the risk of a low anastomosis is sometimes diminished through the creation of a colostomy. Currently, the morbidity and mortality associated with the reversal of the colostomy in this population

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction

PURPOSE: Primary cytoreductive surgery (CRS) and peri-operative intraperitoneal chemotherapy (PIC) is the only curative option for patients with colorectal cancer peritoneal carcinomatosis (PC). A significant proportion of patients develop peritoneal recurrence. Outcomes of patients undergoing secondary CRS and PIC for recurrent PC were examined.METHODS: All patients undergoing second procedures w

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers : methodological update

Background: The 2017 Alzheimer’s disease (AD) Strategic Biomarker Roadmap (SBR) structured the validation of AD diagnostic biomarkers into 5 phases, systematically assessing analytical validity (Phases 1–2), clinical validity (Phases 3–4), and clinical utility (Phase 5) through primary and secondary Aims. This framework allows to map knowledge gaps and research priorities, accelerating the route t